- Approval Id
- 26d82c46923538e1
- Drug Name
- LEUNASE FOR INJECTION 10,000 iu/vial
- Product Name
- LEUNASE FOR INJECTION 10,000 iu/vial
- Approval Number
- SIN01989P
- Approval Date
- 1988-06-23
- Registrant
- KYOWA KIRIN ASIA PACIFIC PTE. LTD.
- Licence Holder
- KYOWA KIRIN ASIA PACIFIC PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Dosage
- **\[DOSAGE AND ADMINISTRATION\]**
The usual dose is 50 to 200 KU/kg to be administered by intravenous drip infusion every day or every other day. The dosage may be adjusted depending on the age and condition of the patient.
**(Preparation)**
See 7. Precautions Concerning Use – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
- Route Of Administration
- INTRAVENOUS
- Indication Info
- **\[INDICATIONS\]**
Acute leukemia (including blastic crisis in chronic leukemia), malignant lymphoma.
- Contraindications
- **CONTRAINDICATIONS**
**(LEUNASE Inj. is contraindicated in the following patients.)**
Patients with a history of serious hypersensitivity to any of the components of the product.
- Atc Code
- L01XX02
- Atc Item Name
- asparaginase
- Pharma Manufacturer Name
- KYOWA KIRIN ASIA PACIFIC PTE. LTD.
- Company Detail Path
- /organization/kyowa-kirin-asia-pacific-pte-ltd
